SecBot SecBot
COURT-RULING ·Filed Mar 30, 2026

REGN

Regeneron
NEUTRAL
Impact 3/10
Horizonweeks Processed7mo ago CourtCourt Ruling · ecf.flsd.uscourts.gov
Court ruling (district)
Actionable Insight • Neutral

Monitor for future docket updates or public filings in this case. Given the lack of accessible information, no immediate trading action is warranted. Be cautious of potential information asymmetry if material details emerge later.

DirectionNeutral
Confidencelow
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$746.75
T+0 close · Mar 30, 2026 · via day close
Latest settled
−16.51%
T+60 · $623.43
Vs SPY
−32.54%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 30 $746.75entry
  2. T+1 · 8mo ago +3.12%α +0.23% · $770.08
  3. T+5 · 7mo ago +1.75%α −2.55% · $759.81
  4. T+20 · 7mo ago −2.33%α −14.93% · $729.36
  5. T+60 · 5mo ago −16.51%α −32.54% · $623.43
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Analysis based on filing metadata only, document content was unavailable. The case 'Fraioli v. Regeneron Pharmaceuticals, Inc.' was filed in the Southern District of Florida, but no substantive ruling or opinion text is accessible to assess the outcome, financial exposure, or business impact.

Court Ruling Details

Court
United States District Court for the Southern District of Florida
Court Level
District
Case Type
other
Ruling Type
other
Outcome
NULL
Precedent Risk
LOW

Key Facts

  • Case: Fraioli v. Regeneron Pharmaceuticals, Inc. et al, filed 2026-03-30 in the Southern District of Florida (Case No. 1:26-cv-20636)
  • No ruling text or docket entries available, only a login redirect for PACER system
  • Plaintiff is Fraioli; Regeneron is named as defendant
  • Nature of suit or claims cannot be determined from available data

Financial Impact

Unknown, no information on damages, injunctions, or settlement

Risk Factors

  • Potential for material undisclosed litigation risk if the case involves securities, product liability, or regulatory claims
  • Low visibility increases uncertainty, which could lead to volatility if details are later disclosed

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
75% bullish (36 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-iczfz1rr-REGN

Track record

53 reports on REGN

Performance horizon

11 of 17 bullish or bearish reports moved the stock their way by T+20. Best: +31.76% at T+20 after the Oct 6, 2026 report. 17 of 21 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $951.23 Now $952.40 +0.12% settles Dec 16
  2. Nov 16, 2026today 144 Neutral 2/10 Entry $948.00 Now $952.40 +0.46% settles Dec 16
  3. Nov 12, 20264d ago Press Release Bullish 5/10 Entry $955.47 Now $952.40 −0.32% settles Dec 14
  4. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $904.35 Now $952.40 +5.31% settles Dec 7
  5. Nov 5, 202611d ago Insider Cluster Neutral 3/10 Entry $904.35 Now $952.40 +5.31% settles Dec 7
  6. Nov 4, 202612d ago 144 Neutral 1/10 Entry $902.90 Now $952.40 +5.48% settles Dec 4
  7. Nov 4, 202612d ago 144 Neutral 2/10 Entry $902.90 Now $952.40 +5.48% settles Dec 4
  8. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
  9. Nov 3, 202613d ago 144 Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
  10. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
Showing 10 of 53

US Market Status

Market Closed · Opens Wed (11h 33m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · ecf.flsd.uscourts.gov Report published Mar 30, 2026